Prof. Dr. Aziz Yazar
Medical Oncology
About Aziz Yazar
Prof. Aziz Yazar is a medical doctor trained at Acıbadem University Faculty of Medicine, graduating in 2010. Since 2007 he has been affiliated with Acıbadem Health Group, where he has contributed to clinical care and patient-focused services. He is an active member of the Turkish Oncology Society and the Istanbul Medical Chamber, reflecting his commitment to professional development and quality practice in oncology and medicine. Known for a patient-centered approach and collaborative teamwork, he combines solid clinical training with ongoing involvement in professional organizations.
Subspecialties
- Small cell lung cancer
- Non-small cell lung cancer
- Advanced non-small cell lung carcinoma
- Stage IV non-small cell lung cancer
- Metastatic renal cell carcinoma
- Neoadjuvant chemotherapy for non-small cell lung cancer
- Gemcitabine and cisplatin chemotherapy
- Cancer chemotherapy
Education
- 2010 Acibadem University Faculty of Medicine
- 2005 Istanbul University Oncology Institute Medical Oncology
- 2004 Istanbul University Institute of Oncology / Associate Professor
- 1997 Istanbul University Istanbul Faculty of Medicine Internal Medicine
- 1986 – 1993 Hacettepe University Faculty of Medicine
Experience
- 2007 Acibadem Health Group
- 2005 – 2007 American Hospital
- 2002 – 2005 Istanbul University Oncology Institute / Medical Oncology
- 1999 – 2002 Mersin University Faculty of Medicine
- 1993 – 1998 Istanbul University Istanbul Faculty of Medicine
Professional Memberships
- Turkish Oncology Society
- Istanbul Medical Chamber
Selected Publications
- Prognostic and predictive value of vascular endothelial growth factor and its soluble receptors, VEGFR-1 and VEGFR-2 levels in the sera of small cell lung cancer patients. Medical Oncology, 25, 394-399 (2008) Üstüner Z, Saip P, Yasasever V, Vural B, Yazar A, Bal C, Öztürk B, Özbek U, Topuz E.
- The role of serum vascular endothelial growth factor and matrix metalloproteinase-9 in predicting response to chemotherapy and prognosis in patients with advanced non-small cell lung carcinoma. Southern Medical Journal, 101, 327-328 (2008) Yazar A, Soydinç H, Ertan E, Yasasever V, Taş F,
- Gemcitabine and cisplatin as neo-adjuvant chemotherapy for non-small cell lung cancer: A phase II study. Lung Cancer, 58, 246-252 (2007) Aydıner A, Kıyık M, Çıkrıkçıoğlu S, Koşar F, Gürses A, Turna A, Yazar A, Dilege Ş, Göksel T, Çakan A.
- Serum vascular endothelial growth factor and Bcl-2 levels and their relationship in stage IV non-small cell lung cancer. Turkish Journal of Oncology, 22, 76-81 (2007) Yazar E, Soydinç H, Yazar A, Özgül A, Taş F, Yasasever V, Çamlıca H, Yılmaz V.
- Prevalence of irritable bowel syndrome in bronchial asthma patients. Respiration, 8, 151-155 (2006). Ertan E, Ozgul MA, Yildiz P, Kadakal F, Camlica H, Yazar A, Yilmaz V.
- Is lower socio-economic status a risk factor for Helicobacter pylori infection in pregnant women with hyperemesis gravidarum. Turk J Gastroenterol, 15, 86-89 (2004) Karaca Ç, Güler N, Yazar A, Çamlıca H, Demir K, Yıldırım G.
- Prognostic factors for survival in metastatic renal cell carcinoma: Experience from a single institution. Thirty-Ninth Annual Meeting of American Society of Clinical Oncology, 1750, Chicago, USA, 2003 Bavbek SE, Yazar A, Başaran M, Onat H,
- Lipid peroxidation and antioxidant levels in hyperthyroidism. Cumhuriyet University Medical Faculty Journal, 22, 196-200 (2000) Akbay E, Tamer L, Konca K, Pata C, Yazar A.
- A case of Stevens-Johnson syndrome associated with cephazoline and paracetamol. Journal of Mersin University Faculty of Medicine, 1, 91-94 (2000) Konca K, Köktürk A, Akbay E, Pata C, Yazar A,
Schedule your appointment with Prof. Dr. Aziz Yazar
Choose a date and time that suits you. Our international patient team will check availability and confirm your appointment — usually within 24 hours.
- 1Choose your date & timePick a preferred day and time slot for your visit.
- 2Share your detailsTell us how to reach you and anything we should know.
- 3We confirm with youOur team confirms the appointment by phone or email.
Request your appointment
This request goes directly to this doctor’s schedule.
Your information stays strictly confidential and is used only to arrange your care.